3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Metastatic Urothelial Cancer
1
Glioblastoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
25
Cisplatin
9
Paclitaxel
6
Fluorouracil
5
Carboplatin
4
Saline Solution
3
Capecitabine
3
Bevacizumab
3
Oxaliplatin
2
Gemcitabine
2
Docetaxel
2
Cetuximab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
lenvatinib
1
Trastuzumab
1
S 1 (combination)
1
Irinotecan
1
IFL protocol
1
Glucose
1
Doxorubicin
1
Brentuximab Vedotin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
sacituzumab govitecan
×
Clear all
No trials found.